Tokuyama (4043) Q3 2026 earnings summary

Executive summary

• Sales increased due to the consolidation of the Life Science (TLS) Group and higher semiconductor-related product sales, but overall revenue declined year-over-year due to falling overseas PVC/vinyl chloride market prices.

• Operating profit rose 26.9% year-over-year, driven by strong semiconductor-related sales and improved manufacturing costs.

• Net income attributable to parent company shareholders increased 12% to ¥18.8 billion.

• Comprehensive income surged 58.1% year-over-year to ¥24,494 million.

• Full-year earnings forecast was revised downward based on progress through the third quarter.

Financial highlights

• Revenue for Q3 FY2026 was ¥251.5 billion, down ¥1.8 billion (1%) year-over-year.

• Operating profit rose to ¥26.7 billion, up ¥5.6 billion (27%) year-over-year.

• Ordinary profit increased to ¥27.4 billion, up 25% year-over-year.

• Net income attributable to parent company shareholders was ¥18.8 billion, up 12% year-over-year.

• EPS for the period was ¥262.28, up from ¥235.15 year-over-year.

Outlook and guidance

• Full-year revenue forecast revised down to ¥351.5 billion, with operating profit at ¥39.0 billion and net income at ¥27.5 billion.

• Dividend forecast raised to ¥120 per share for FY2025.

• Segment forecasts adjusted: lower for Chemicals and Life Science, higher for Electronics and Cement.